GBFH vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
GBFH presents a contradictory profile, characterized by a weak deterministic health baseline with a Piotroski F-Score of 3/9 and a bearish technical trend (0/100). While the company demonstrates strong top and bottom-line growth (Revenue +29.4%, Earnings +37.5% YoY), these fundamentals are undermined by a poor recent earnings track record (only 1 of the last 4 quarters beat estimates). The stock is currently priced at $29.10, sitting between its defensive Graham Number ($19.52) and its growth-based intrinsic value ($43.37). The combination of strong growth and weak financial health/insider sentiment suggests a high-risk, high-reward scenario.
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Compare Another Pair
Related Comparisons
GBFH vs JPM: Head-to-Head Comparison
This page compares GBank Financial Holdings Inc. (GBFH) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.